Source: BioPortfolio

Endocyte: Endocyte Inc ECYT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250

SummaryEndocyte Inc Endocyte is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company's pipeline products include LuPSMA617 and AcPSMA617 for radiologand therapy and FITC CART. Endoc...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more